GGrantIndex
Sort

35,931 grants matching parkinsons

Imaging of Neuropsychiatric Disorders with Developmental and Genetic Mechanisms

$834,101
Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2014 · MH

Genetic Basis Of Cortical Malfunction In Schizophrenia

$834,101
Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2014 · MH

Regulation of tau expression in Alzheimer disease and aging

$834,068
John Fonda Crary · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · AG

Motor and Cognitive Health Outcomes in a Mn-Exposed African Community

$833,930
Brad A Racette · Washington University · R01 · FY2017 · ES

Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells

$833,765
Leslie Michels Thompson · University Of California-Irvine · U54 · FY2016 · NS

Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells

$833,765
Leslie Michels Thompson · University Of California-Irvine · U54 · FY2018 · NS

The chromatin-based epigenome in development and aging

$833,436
Bruce H. Howard · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD

Toxicant-induced neurotoxicity mediated by glia-neuron and gene-environment interactions in Parkinson's disease

$833,153
Kim Tieu · Florida International University · R35 · FY2021 · ES

Toxicant-induced neurotoxicity mediated by glia-neuron and gene-environment interactions in Parkinson's disease

$833,152
Kim Tieu · Florida International University · R35 · FY2023 · ES

Toxicant-induced neurotoxicity mediated by glia-neuron and gene-environment interactions in Parkinson's disease

$833,152
Kim Tieu · Florida International University · R35 · FY2022 · ES

Core B - Clinical Core

$832,933
Teresa Gomez-Isla · Massachusetts General Hospital · P50 · FY2017 · AG

Sigma-1 Receptor Radioligand for Translational Research in Alzheimer's Disease

$832,864
Yiyun Henry Huang · Yale University · R56 · FY2022 · AG

MITOCHONDRIAL IMPAIRMENT IN ALZHEIMERS DISEASE

$832,845
University Of Virginia Charlottesville · P01 · FY2000 · AG

Metabolic Control Analysis

$832,499
Richard L Veech · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA

Oxidative DNA Damage And Its Processing

$832,475
Vilhelm A Bohr · National Institute On Aging · ZIA · FY2016 · AG

Controlled Trial of DBS for OCD

$832,319
Benjamin D Greenberg · Butler Hospital (Providence, Ri) · U01 · FY2006 · MH

Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome

$831,388
Martha J Morrell · Neuropace, Inc. · UH3 · FY2021 · NS

Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins

$831,256
Vikram Khurana · Brigham And Women'S Hospital · R01 · FY2023 · NS

Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins

$831,256
Vikram Khurana · Brigham And Women'S Hospital · R01 · FY2025 · NS

Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins

$831,256
Vikram Khurana · Brigham And Women'S Hospital · R01 · FY2024 · NS

Light Imaging Core Facility

$831,096
Carolyn Smith · National Institute Of Neurological Disorders And Stroke · ZIC · FY2022 · NS

Prospective studies on Parkinson's disease

$830,575
Honglei Chen · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

Investigating the Neurobiology of Early Cognitive Impairment

$830,339
George W. Huntley · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · NS

CRCNS Research Proposal: Contributions of the Thalamus and Basal Ganglia to Neocortical Beta Oscillation: A Novel Computational Hypothesis

$830,000
Christopher Moore · Brown University · · FY2011 · CSE

Discovery and validation of multi-omic plasma biomarkers for Adrenomyeloneuropathy

$829,626
S. Ali Fatemi · Hugo W. Moser Res Inst Kennedy Krieger · R61 · FY2024 · NS